Robert Pytlík

2.3k total citations
91 papers, 1.5k citations indexed

About

Robert Pytlík is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Robert Pytlík has authored 91 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Pathology and Forensic Medicine, 36 papers in Genetics and 31 papers in Oncology. Recurrent topics in Robert Pytlík's work include Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Viral-associated cancers and disorders (15 papers). Robert Pytlík is often cited by papers focused on Lymphoma Diagnosis and Treatment (45 papers), Chronic Lymphocytic Leukemia Research (21 papers) and Viral-associated cancers and disorders (15 papers). Robert Pytlík collaborates with scholars based in Czechia, Germany and United States. Robert Pytlík's co-authors include Tomáš Kozák, Marek Trněný, Tomáš Soukup, Jana Karbanová, Jakub Suchánek, Pavel Klener, Marie Hubálek Kalbáčová, David Belada, J Živný and Jaroslav Mokrý and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Robert Pytlík

85 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Pytlík Czechia	23	499	483	473	457	267	91	1.5k
Fabrizio Vianello Italy	18	520 1.0×	408 0.8×	901 1.9×	247 0.5×	801 3.0×	89	2.2k
Kazuya Sato Japan	17	533 1.1×	951 2.0×	356 0.8×	174 0.4×	410 1.5×	78	2.0k
Αthanasios Fassas Greece	26	419 0.8×	838 1.7×	657 1.4×	1.2k 2.6×	677 2.5×	65	2.6k
Patrick Wuchter Germany	27	575 1.2×	581 1.2×	692 1.5×	150 0.3×	280 1.0×	119	2.1k
Olli Tynninen Finland	24	710 1.4×	496 1.0×	460 1.0×	115 0.3×	340 1.3×	64	2.0k
Udo Holtick Germany	25	337 0.7×	322 0.7×	728 1.5×	326 0.7×	631 2.4×	87	1.9k
Satoru Otsuru United States	26	750 1.5×	624 1.3×	242 0.5×	146 0.3×	211 0.8×	65	2.1k
Michael P. Gustafson United States	28	732 1.5×	482 1.0×	1.3k 2.8×	163 0.4×	1.2k 4.4×	67	2.8k
Zhigui Ma China	22	991 2.0×	166 0.3×	484 1.0×	455 1.0×	132 0.5×	56	2.5k
Francesca Maria Rossi Italy	25	459 0.9×	867 1.8×	353 0.7×	704 1.5×	684 2.6×	84	1.9k

Countries citing papers authored by Robert Pytlík

Since Specialization

Citations

This map shows the geographic impact of Robert Pytlík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pytlík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pytlík more than expected).

Fields of papers citing papers by Robert Pytlík

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Pytlík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pytlík. The network helps show where Robert Pytlík may publish in the future.

Co-authorship network of co-authors of Robert Pytlík

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Pytlík. A scholar is included among the top collaborators of Robert Pytlík based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Pytlík. Robert Pytlík is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Móciková, Heidi, Andrea Janíková, Vít Procházka, et al.. (2024). Outcome of patients with diffuse large B-cell lymphoma and testicular involvement – real world data. Annals of Hematology. 104(1). 675–684.

Otáhal, Pavel, et al.. (2022). Chimeric Antigen Receptor Based Cellular Therapy for Treatment Of T-Cell Malignancies. Frontiers in Oncology. 12. 876758–876758. 14 indexed citations

Pytlík, Robert, et al.. (2022). Cytomegalovirus and other herpesviruses after hematopoietic cell and solid organ transplantation: From antiviral drugs to virus-specific T cells. Transplant Immunology. 71. 101539–101539. 12 indexed citations

Janečková, Lucie, Touati Benoukraf, Roberto Tirado-Magallanes, et al.. (2020). β-Catenin–TCF/LEF signaling promotes steady-state and emergency granulopoiesis via G-CSF receptor upregulation. Blood. 136(22). 2574–2587. 43 indexed citations

Beranek, P.A., et al.. (2018). [Non-Hodgkin´s B-lymphoma of the ovaries with an unfavourable prognosis - incidental finding during caesarean section].. PubMed. 83(1). 45–49. 1 indexed citations

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2018). The incidence of biopsy-proven transformation in follicular lymphoma in the rituximab era. A retrospective analysis from the Czech Lymphoma Study Group (CLSG) database. Annals of Hematology. 97(4). 669–678. 13 indexed citations

Klánová, Magdalena, Ladislav Anděra, Jan Bražina, et al.. (2015). Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma. Clinical Cancer Research. 22(5). 1138–1149. 72 indexed citations

Pytlík, Robert, et al.. (2014). Evaluation of Sericin as a Fetal Bovine Serum-Replacing Cryoprotectant During Freezing of Human Mesenchymal Stromal Cells and Human Osteoblast-Like Cells. Biopreservation and Biobanking. 12(2). 99–105. 32 indexed citations

Malíková, Hana, et al.. (2014). Complications of MRI-guided stereotactic biopsy of brain lymphoma.. PubMed. 35(7). 613–8. 16 indexed citations

10.

Janíková, Andrea, Zbyněk Bortlíček, Vít Campr, et al.. (2013). Radiotherapy With Rituximab Is Better than Radiotherapy alone In First Line Treatment Of Localized Follicular Lymphoma. Time To Change a Standard Strategy?. Blood. 122(21). 4388–4388. 3 indexed citations

11.

Pytlík, Robert, et al.. (2012). Xenogeneic Protein-Free Cultivation of Mesenchymal Stromal Cells – Towards Clinical Applications. Folia Biologica. 58(3). 106–114. 3 indexed citations

12.

Móciková, Heidi, Robert Pytlík, Jana Marková, et al.. (2011). Pre-transplant positron emission tomography in patients with relapsed Hodgkin lymphoma. Leukemia & lymphoma. 52(9). 1668–1674. 40 indexed citations

13.

Pytlík, Robert, Tomáš Soukup, Marie Hubálek Kalbáčová, et al.. (2009). The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials. 30(20). 3415–3427. 30 indexed citations

14.

Živný, J, Pavel Klener, Robert Pytlík, & Ladislav Anděra. (2009). The Role of Apoptosis in Cancer Development and Treatment: Focusing on the Development and Treatment of Hematologic Malignancies. Current Pharmaceutical Design. 16(1). 11–33. 35 indexed citations

15.

Rodriguez, Maria Alma, Robert Pytlík, Tomáš Kozák, et al.. (2009). Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non‐Hodgkin lymphoma. Cancer. 115(15). 3475–3482. 105 indexed citations

16.

Závada, Jakub, et al.. (2008). Circulating Endothelial Cells and Circulating Endothelial Progenitors in Kidney Disease – Victims, Witnesses, or Accomplices?. Folia Biologica. 54(3). 73–80. 4 indexed citations

17.

Lacina, Lukáš, Karel Smetana, Barbora Dvořánková, et al.. (2007). Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes. British Journal of Dermatology. 156(5). 819–829. 46 indexed citations

18.

Schwarz, Jiřı́, Robert Pytlík, Michael Doubek, et al.. (2006). Analysis of Risk Factors: The Rationale of the Guidelines of the Czech Hematological Society for Diagnosis and Treatment of Chronic Myeloproliferative Disorders with Thrombocythemia. Seminars in Thrombosis and Hemostasis. 32(3). 231–245. 6 indexed citations

19.

Pytlík, Robert, Marek Trněný, David Belada, et al.. (2005). Treatment of High Risk Diffuse Large B-Cell Lymphomas (DLBCL) with Ntensive Induction Chemotherapy, Rituximab and Autologous Stem Cell Transplant.. Blood. 106(11). 1506–1506. 1 indexed citations

20.

Smetana, Karel, Barbora Dvořánková, Zuzana Holı́ková, et al.. (2003). New aspects of galectin functionality in nuclei of cultured bone marrow stromal and epidermal cells: biotinylated galectins as tool to detect specific binding sites. Biology of the Cell. 95(8). 535–545. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact